Tecan shares rose after the laboratory instruments company said late Wednesday that it met its sales target for 2024. Shares rose 7.8% in early-morning trading to 229.80 Swiss francs, but remain ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NeuroPace (NPCE – Research Report), Tecan Group AG (TCHBF – Research Report) and Avidity ...
Additional participants: Tania Micki, CFO & Martin Brändle, SVP, Corp. Comm. & Investor Relations Webcast live under the “Investor Relations” tab of Tecan’s website www.tecan.com. A replay of the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...